TGFB1 and pulmonary fibrosis: Taken together, these observations indicate that CAPE acts on at least two of the most crucial mediators implicated in lung fibrosis, improving the balance between profibrotic (TGF-β1) and antifibrotic anti-fibrotic (PGE2) mediators.